Oncology Institute Inc [NASDAQ: TOI] loss -1.54% on the last trading session, reaching $3.20 price per share at the time.
If compared to the average trading volume of 1.26M shares, TOI reached a trading volume of 6113824 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Oncology Institute Inc [TOI]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TOI shares is $7.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TOI stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BTIG Research have made an estimate for Oncology Institute Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 15, 2025. While these analysts kept the previous recommendation, Jefferies raised their target price to Buy. The new note on the price target was released on February 26, 2024, representing the official price target for Oncology Institute Inc stock. Previously, the target price had yet another raise to $7, while Guggenheim analysts kept a Buy rating on TOI stock.
The Average True Range (ATR) for Oncology Institute Inc is set at 0.37, with the Price to Sales ratio for TOI stock in the period of the last 12 months amounting to 0.71. The Price to Book ratio for the last quarter was 56.14, with the Price to Cash per share for the same quarter was set at 0.45.
Trading performance analysis for TOI stock
Oncology Institute Inc [TOI] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.31. With this latest performance, TOI shares gained by 14.29% in over the last four-week period, additionally plugging by 1782.35% over the last 6 months – not to mention a rise of 579.84% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TOI stock in for the last two-week period is set at 61.33, with the RSI for the last a single of trading hit 61.76, and the three-weeks RSI is set at 61.71 for Oncology Institute Inc [TOI]. The present Moving Average for the last 50 days of trading for this stock 2.35, while it was recorded at 3.19 for the last single week of trading, and 0.92 for the last 200 days.
Oncology Institute Inc [TOI]: A deeper dive into fundamental analysis
Oncology Institute Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.59 and a Current Ratio set at 1.79.
An analysis of Institutional ownership at Oncology Institute Inc [TOI]
The top three institutional holders of TOI stocks are: FMR LLC with ownership of 4.75 million shares, which is approximately 6.4005%. DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), holding 3.36 million shares of the stock with an approximate value of $$1.55 million in TOI stocks shares; and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), currently with $$0.82 million in TOI stock with ownership which is approximately 2.4025%.
